LOX and breast cancer: With increasing tumor mass, hypoxia often results from insufficient blood supply to the cancer cells, and tumor microenvironmental hypoxia induces increased expression of hypoxia inducible factor-1α (HIF-1α), leading to the release of LOX, an enzyme that crosslinks extracellular matrix proteins such as collagen and promotes breast cancer metastasis.